7Ridker PM,Rifai N,Stampfer M J,et al.plasma concentration of interleukin -6 and the risk offusture myocardial infarction among apparently healthymen[J].Circulation,2000,101 (15):1767.
9Brown DL,Hibbs MS,Kearney M,et al.Identification of 92-KD gelatinase in human coronary atherosclerotic lesions.Association of active enzyme synthesis is with unstable angina[J].Circulation,1995,91 (8):2125-31.
10Abe N,Osanai T,Fujiwara T,et al.C-reactive protein-induced upregulation of extracellular matrix metalloproteinase inducer in macrophages:Inhibitory effect of fluvastatin.Life Sciences,2006,7 (9):1021-1028.
2Newby AC. Matrix metalloproteinases regulate migration,proliferation,and death of vascular cells by degrading matrix and non-matrix substrates[J].Cardiovascular Research,2006,(03):614-624.
3Suh SJ,Kim JR,Jin UH. Deoxypodophyllotoxin,flavolignan,from AnthAnth riscus sylvestris Hoffm.inhibits migration and MMP-9 viaMAPK pathways in TNF-alpha induced HASMC[J].Vascular Pharmacology,2009,(01):13-20.
4Lee YH,Kim TY,Hong YM. Metalloproteinase-3 genotype as apredictor of cardiovascular risk in hypertensive adolescents[J].Korean Circ J,2009,(08):328-334.
5Murphy G,Nagase H. Progress in matrix metalloproteinase research[J].Molecular Aspects of Medicine,2008,(05):290-308.doi:10.1016/j.mam.2008.05.002.
6Luttun A,Lutgens E,Manderveld A. Loss of matrix metalloproteinase-9 or matrix metalloproteinase-12 protects apolipoprotein E-deficentmice against atherosclerotic media destruction but differentially affects plaque growth[J].Circulation,2004,(11):1408-1414.doi:10.1161/01.CIR.0000121728.14930.DE.
8Kobayashi N,Hata N,Kume N. Matrix Metalloproteinase-9 for the Earliest Stag Acute Coronary Syndrome[J].Circulation,2011,(12):2853-2861.
9Xie P,Cao YS,Su P. Expression of toll-Like receptor 4,tumor necrosis factor-Alpha,Matrix Metalloproteinase-9 and effects of benazepril in patients with acute coronary syndromes[J].Clinical Medicine Insights Cardiology,2010.89-93.
10Manginas A,Bei E,Chaidaroglou A. Peripheral levels of matrix metallop-roteinase-9,interleukin-6,and C-reactive protein are elevated in patients with acute coronary syndromes:correlations with serumtroponin I[J].Clinical Cardiology,2005,(04):182-186.doi:10.1002/clc.4960280405.
